Page last updated: 2024-10-25

dapsone and Dihydropyrimidine Dehydrogenase Deficiency

dapsone has been researched along with Dihydropyrimidine Dehydrogenase Deficiency in 1 studies

Dihydropyrimidine Dehydrogenase Deficiency: An autosomal recessive disorder affecting DIHYDROPYRIMIDINE DEHYDROGENASE and causing familial pyrimidinemia. It is characterized by thymine-uraciluria in homozygous deficient patients. Even a partial deficiency in the enzyme leaves individuals at risk for developing severe 5-FLUOROURACIL-associated toxicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenfield, NP1
Maibach, H1

Other Studies

1 other study available for dapsone and Dihydropyrimidine Dehydrogenase Deficiency

ArticleYear
Pharmacogenomic biomarkers in dermatologic drugs.
    The Journal of dermatological treatment, 2013, Volume: 24, Issue:6

    Topics: Androstenes; Aryl Hydrocarbon Hydroxylases; Biomarkers; Chloroquine; Cytochrome P-450 CYP2C19; Cytoc

2013